These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 27708347

  • 21. Type III interferon-induced CBFβ inhibits HBV replication by hijacking HBx.
    Xu F, Song H, Xiao Q, Li N, Zhang H, Cheng G, Tan G.
    Cell Mol Immunol; 2019 Apr; 16(4):357-366. PubMed ID: 29523836
    [Abstract] [Full Text] [Related]

  • 22. Hepatitis B virus X protein promotes interleukin-7 receptor expression via NF-κB and Notch1 pathway to facilitate proliferation and migration of hepatitis B virus-related hepatoma cells.
    Kong F, Hu W, Zhou K, Wei X, Kou Y, You H, Zheng K, Tang R.
    J Exp Clin Cancer Res; 2016 Nov 07; 35(1):172. PubMed ID: 27821177
    [Abstract] [Full Text] [Related]

  • 23. Silencing Retinoid X Receptor Alpha Expression Enhances Early-Stage Hepatitis B Virus Infection In Cell Cultures.
    Song M, Sun Y, Tian J, He W, Xu G, Jing Z, Li W.
    J Virol; 2018 Apr 15; 92(8):. PubMed ID: 29437960
    [Abstract] [Full Text] [Related]

  • 24. Hepatitis B virus induces cell proliferation via HBx-induced microRNA-21 in hepatocellular carcinoma by targeting programmed cell death protein4 (PDCD4) and phosphatase and tensin homologue (PTEN).
    Damania P, Sen B, Dar SB, Kumar S, Kumari A, Gupta E, Sarin SK, Venugopal SK.
    PLoS One; 2014 Apr 15; 9(3):e91745. PubMed ID: 24633222
    [Abstract] [Full Text] [Related]

  • 25. A novel mutant 10Ala/Arg together with mutant 144Ser/Arg of hepatitis B virus X protein involved in hepatitis B virus-related hepatocarcinogenesis in HepG2 cell lines.
    Shi Y, Wang J, Wang Y, Wang A, Guo H, Wei F, Mehta SR, Espitia S, Smith DM, Liu L, Zhang Y, Chen D.
    Cancer Lett; 2016 Feb 28; 371(2):285-91. PubMed ID: 26706415
    [Abstract] [Full Text] [Related]

  • 26. HBx represses WDR77 to enhance HBV replication by DDB1-mediated WDR77 degradation in the liver.
    Yuan H, Zhao L, Yuan Y, Yun H, Zheng W, Geng Y, Yang G, Wang Y, Zhao M, Zhang X.
    Theranostics; 2021 Feb 28; 11(17):8362-8378. PubMed ID: 34373747
    [Abstract] [Full Text] [Related]

  • 27. Reversal of hepatitis B virus-induced immune tolerance by an immunostimulatory 3p-HBx-siRNAs in a retinoic acid inducible gene I-dependent manner.
    Han Q, Zhang C, Zhang J, Tian Z.
    Hepatology; 2011 Oct 28; 54(4):1179-89. PubMed ID: 21721030
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Targeted HBx gene editing by CRISPR/Cas9 system effectively reduces epithelial to mesenchymal transition and HBV replication in hepatoma cells.
    Rawal P, Tripathi DM, Hemati H, Kumar J, Tyagi P, Sarin SK, Nain V, Kaur S.
    Liver Int; 2024 Feb 28; 44(2):614-624. PubMed ID: 38105495
    [Abstract] [Full Text] [Related]

  • 36. Anti-HBV drugs suppress the growth of HBV-related hepatoma cells via down-regulation of hepatitis B virus X protein.
    Zhang S, Gao S, Zhao M, Liu Y, Bu Y, Jiang Q, Zhao Q, Ye L, Zhang X.
    Cancer Lett; 2017 Apr 28; 392():94-104. PubMed ID: 28192212
    [Abstract] [Full Text] [Related]

  • 37. Epigenetic repression of miR-132 expression by the hepatitis B virus x protein in hepatitis B virus-related hepatocellular carcinoma.
    Wei X, Tan C, Tang C, Ren G, Xiang T, Qiu Z, Liu R, Wu Z.
    Cell Signal; 2013 May 28; 25(5):1037-43. PubMed ID: 23376496
    [Abstract] [Full Text] [Related]

  • 38. [Interleukin-35 induced by hepatitis B virus inhibits viral replication and viral antigen secretion in hepatocytes].
    Yang K, Pan Y, Yan B.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2022 Sep 28; 38(9):776-780. PubMed ID: 36082706
    [Abstract] [Full Text] [Related]

  • 39. [Induction of SMYD3 by hepatitis B virus X gene in HepG2 cells].
    Yang L, Ren J, He J, Chen LB.
    Zhonghua Gan Zang Bing Za Zhi; 2009 Apr 28; 17(4):297-300. PubMed ID: 19403031
    [Abstract] [Full Text] [Related]

  • 40. S-phase arrest after vincristine treatment may promote hepatitis B virus replication.
    Xu L, Tu Z, Xu G, Hu JL, Cai XF, Zhan XX, Wang YW, Huang Y, Chen J, Huang AL.
    World J Gastroenterol; 2015 Feb 07; 21(5):1498-509. PubMed ID: 25663769
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.